Figures & data
Table 1 Demographic and clinical characteristics of patients who received donepezil or placebo
Table 2 Neuropsychological test scores of patients with schizophrenia who received donepezil or placebo
Figure 2 Effect size of change in domain scores after 12 weeks of treatment with donepezil or placebo in patients with schizophrenia.
![Figure 2 Effect size of change in domain scores after 12 weeks of treatment with donepezil or placebo in patients with schizophrenia.](/cms/asset/dad66af4-bb90-4356-a104-977b9d59603a/dndt_a_64189_f0002_b.jpg)
Table 3 Safety measures of patients with schizophrenia who received donepezil or placebo